SDMC (00901) intends to cooperate with Altice Labs to jointly explore, co-develop, and validate TV-centric AI Home products, application scenarios, and services.
SDMC (00901) announced that on November 17, 2026, the Company entered into a memorandum of understanding with Altice Labs, S.A. Pursuant to the MOU, the Company intends to cooperate with Altice Labs to jointly explore, co-develop, and validate TV-centric AI Home products, application scenarios, and services, and to evaluate their commercial value and scalability for operators to provide home services.
SDMC (00901) announced that on November 17, 2026, the Company entered into a memorandum of understanding with Altice Labs, S.A. Pursuant to the MOU, the Company intends to cooperate with Altice Labs to jointly explore, co-develop and validate TV-centric AI Home products, application scenarios and services, and to evaluate their commercial value and scalability for operators to provide home services.
Pursuant to the MOU, the parties agreed to cooperate in areas including product and device innovation, AI scenario co-creation, edge AI, ecosystem integration and business model validation. The parties will use the TV as the shared home entry point, focusing on exploring applications such as home intelligent assistants, home security and status sensing, and smart home control, so that AI capabilities can extend from single-device functions to a more complete home service experience.
Pursuant to the MOU, at the technical level, the parties will combine Google Cloud AI capabilities with the Google TV ecosystem to promote the development and validation of relevant home AI scenarios. In addition, the parties plan to carry out a real-home pilot project, including establishing a joint AI Home innovation laboratory and taking the lead in conducting on-site pilots of selected AI Home scenarios in Portugal, with the goal of achieving commercial validation by the end of 2027. The pilot will focus on evaluating the actual use value, technical reliability and service delivery feasibility of the relevant scenarios, and explore their commercial potential for integration into operators' existing business systems, providing a basis for subsequent product development and large-scale deployment.
The Board believes that entering into the MOU is in line with the Group's AI Home strategy and long-term development direction. By leveraging the parties' complementary advantages, it advances the joint development, technical adaptation and validation of TV-centric AI Home products, application scenarios and services. In particular, given that the Company has previously been selected for Google Cloud's "Agentspace" proactive Physical AI acceleration program, the Company believes that through further cooperation with Altice Labs, it will be able to leverage the program's technical experts, AI cloud resources and ecosystem support to further advance AI Home technological innovation and the exploration of new applications.
The Board believes that entering into the MOU will help the Group advance AI Home product innovation and application scenario validation, deepen its understanding of operators' needs and enhance its ability to respond to such needs, and lay the foundation for the future development of the Group's AI Home business.
It is reported that Altice Labs is a leading company incorporated under the laws of the Portuguese Republic that develops advanced connectivity solutions. As part of the Altice Group, Altice Labs supports telecom operators and enterprises worldwide through next-generation technologies that enhance performance, efficiency and customer experience.
Related Articles

YUM CHINA (09987) repurchased 35,600 shares on November 16 for approximately HK$14.1806 million.

GLOBAL BIO-CHEM (00809) intends to sell all equity interests in Changchun Dacheng Bio-Technology through public tender.

NIKE, Inc. Class B (NKE.US) lays out a clear growth path for the next five years: targeting US$5 billion in incremental revenue by fiscal 2031.
YUM CHINA (09987) repurchased 35,600 shares on November 16 for approximately HK$14.1806 million.

GLOBAL BIO-CHEM (00809) intends to sell all equity interests in Changchun Dacheng Bio-Technology through public tender.

NIKE, Inc. Class B (NKE.US) lays out a clear growth path for the next five years: targeting US$5 billion in incremental revenue by fiscal 2031.






